-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Tonix Pharmaceuticals Holding Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Tonix Pharmaceuticals Holding Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was -$15.6M, a 44.7% increase year-over-year.
- Tonix Pharmaceuticals Holding Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$142M, a 14.4% decline year-over-year.
- Tonix Pharmaceuticals Holding Corp. annual Operating Income (Loss) for 2023 was -$118M, a 5.61% decline from 2022.
- Tonix Pharmaceuticals Holding Corp. annual Operating Income (Loss) for 2022 was -$112M, a 21.4% decline from 2021.
- Tonix Pharmaceuticals Holding Corp. annual Operating Income (Loss) for 2021 was -$92.3M, a 82.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)